Genexine Merges With EPD Biotherapeutics To Boost Drug Pipeline
04 Jul 2024 //
BUSINESSWIRE
Genexine`s weekly growth hormone equal to Novo shot in phase 3
31 Aug 2023 //
FIERCE BIOTECH
Genexine Abstract on GX-188E and GX-I7 Therapy in HNSCC Is Released
26 May 2023 //
BUSINESSWIRE
Genexine says long-acting anaemia therapy succeeds against Roche, CSL`s Mircera
12 Apr 2023 //
BUSINESSWIRE
Genexine Receives Fast Track Designation from MFDS for DNA vaccine
20 Jan 2023 //
BUSINESSWIRE
Genexine to Present Final Phase 2 Clinical Data on Its Cervical Cancer Program
08 Jan 2023 //
BUSINESSWIRE
Genexine’s DNA Vaccine Shows Potential to Extend Survival in Cervical Cancer
07 Sep 2022 //
BUSINESSWIRE
Genexine selected for Presentation of PII Study of GX-188E
25 Aug 2022 //
BUSINESSWIRE
Patient with HNSCC dosed with triple combo therapy in PII of Genexine trial
17 Aug 2022 //
PHARMAFILE
Genexine Completes Enrollment in PIII Trial with GX-H9/TJ101
14 Jun 2022 //
BIOSPACE
Genexine reports encouraging top-line results of PI/II trial with GX-I7
06 Jun 2022 //
BUSINESSWIRE
Genexine to Present at H.C. Wainwright Global Investment Conference
24 May 2022 //
BUSINESSWIRE
Genexine Appoints Industry Veteran Neil Warma as CEO
24 May 2022 //
BUSINESSWIRE
S. Korean drug firms rush to develop vaccines effective against omicron
18 Dec 2021 //
KOREAHERALD
Genexine to supply Covid-19 vaccine candidate to Indonesia
27 Apr 2021 //
KOREABIOMED
KGBio and Genexine Signed Immuno-Oncology Drug License Agreement GX-17
19 Feb 2021 //
PRESS RELEASE
Genexine expected to apply for approval of Covid-19 vaccine next fall: CEO
14 Nov 2020 //
FIRSTWORDPHARMA
Genexine and NeoImmuneTech Announce Data Release for their Phase 1b/2 Study
10 Nov 2020 //
BIOSPACE
Genexine’s growth hormone therapy to enter P3 trials in China
05 Oct 2020 //
KOREA BIOMEDICAL REVIEW
Genexine’s growth hormone therapy to enter P3 trials in China
05 Oct 2020 //
KOREA BIOMEDICAL REVIEW
I-Mab Receives China CDE Approval to Initiate Ph 3 Trial of Eftansomatropin
30 Sep 2020 //
PRNASIA
PharmaJet collaborates with Korea for COVID-19 vaccine delivery
15 Sep 2020 //
BIOSPECTRUM ASIA
Genexine’s cytokine drug effective in treating coronavirus patients
27 Aug 2020 //
PHARMAFILE
Genexine begins global P3 trial of anemia drug
23 Aug 2020 //
KOREABIOMEDICALREVIEW
South Korea approves human trial for Genexine`s coronavirus treatment drug
07 Aug 2020 //
REUTERS
South Korea approves human trial for Genexine`s coronavirus treatment drug
06 Aug 2020 //
REUTERS
BIA Separations extends coverage in APAC
13 Jul 2020 //
BIOSPECTRUMASIA
I-Mab & Genexine Announce China NMPA Clearance for Ph2 Trial of TJ107/HyLeukin-7
21 May 2020 //
PR NEWSWIRE
Genexine consortium develops COVID-19 vaccine for human testing
17 May 2020 //
KOREAHERALD
I-Mab, Kalbe Genexine Enter Strategic Pact
31 Mar 2020 //
CONTRACT PHARMA
Genexine, Binex to co-develop coronavirus vaccine GX-19
16 Mar 2020 //
KOREAHERALD